PDE2 and 5 inhibitors and cognitive function

被引：0
|
作者：
Prickaerts, J. [1 ]
Rutten, K. [1 ]
Reneerkens, O. [1 ]
Sik, A. [1 ]
Blokland, A. [1 ,2 ]
Steinbusch, H. W. M. [1 ]
机构：
[1] Maastricht Univ, European Grad Sch Neurosci, Dept Psychiat & Neuropsychol, Maastricht, Netherlands
[2] Maastricht Univ, Fac Psychol, Dept Neurocognit, Maastricht, Netherlands
来源：
BEHAVIOURAL PHARMACOLOGY | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号：
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要：
引用
收藏
页码：S8 / S8
页数：1
相关论文
共 50 条
  • [1] PDE2 inhibition: Potential for the treatment of cognitive disorders
    Gomez, Laurent
    Breitenbucher, J. Guy
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (24) : 6522 - 6527
  • [2] Design of PDE2 inhibitors with free-energy perturbation
    Tresadern, Gary
    van Roosbroeck, Yves
    Velter, Ingrid
    Buijnsters, Peter
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [3] Discovery of potent, selective, bioavailable phosphodiesterase 2 (PDE2) inhibitors active in an osteoarthritis pain model, Part I: Transformation of selective pyrazolodiazepinone phosphodiesterase 4 (PDE4) inhibitors into selective PDE2 inhibitors
    Plummer, Mark S.
    Cornicelli, Joseph
    Roark, Howard
    Skalitzky, Donald J.
    Stankovic, Charles J.
    Bove, Susan
    Pandit, Jayvardhan
    Goodman, Annise
    Hicks, James
    Shahripour, Aurash
    Beidler, David
    Lu, Xiao Kang
    Sanchez, Brian
    Whitehead, Christopher
    Sarver, Ron
    Braden, Timothy
    Gowan, Richard
    Shen, Xi Qiang
    Welch, Katherine
    Ogden, Adam
    Sadagopan, Nalini
    Baum, Heidi
    Miller, Howard
    Banotai, Craig
    Spessard, Cindy
    Lightle, Sandra
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (11) : 3438 - 3442
  • [4] Activation of PDE2 and PDE5 by specific GAF ligands: delayed activation of PDE5
    Jaeger, Ronald
    Schwede, Frank
    Genieser, Hans-Gottfried
    Koesling, Doris
    Russwurm, Michael
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 161 (07) : 1645 - 1660
  • [5] Et Tu PDE2?
    Kass, David A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (17) : 1607 - 1609
  • [6] Selective Inhibitors of PDE2, PDE9, and PDE10: Modulators of Activity of the Central Nervous System
    Jorgensen, Morten
    Kehler, Jan
    Langgard, Morten
    Svenstrup, Niels
    Tagmose, Lena
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 48, 2013, 48 : 37 - 55
  • [7] VEGF-induced HUVEC migration and proliferation are decreased by PDE2 and PDE4 inhibitors
    Favot, L
    Keravis, T
    Holl, V
    Le Bec, A
    Lugnier, C
    THROMBOSIS AND HAEMOSTASIS, 2003, 90 (02) : 334 - 343
  • [8] A new chemical tool for exploring the physiological function of the PDE2 isozyme
    Chambers, RJ
    Abrams, K
    Garceau, NY
    Kamath, AV
    Manley, CM
    Lilley, SC
    Otte, DA
    Scott, DO
    Sheils, AL
    Tess, DA
    Vellekoop, AS
    Zhang, Y
    Lam, KT
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (02) : 307 - 310
  • [9] Inhibition of PDE2, PDE5 and PDE10: Effects on short-term memory
    Reneerkens, O. A. H.
    Rutten, K.
    Sik, A.
    Blokland, A.
    Steckler, T.
    Steinbusch, H. W. M.
    Prickaerts, J.
    BEHAVIOURAL PHARMACOLOGY, 2008, 19 (5-6): : 670 - 670
  • [10] Inhibition of PDE2 and PDE5: Effects on object recognition and object location memory
    Reneerkens, O. A. H.
    Rutten, K.
    Sik, A.
    Steinbusch, H. W. M.
    Blokland, A.
    Prickaerts, J.
    BEHAVIOURAL PHARMACOLOGY, 2007, 18 : S100 - S100
12345